Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 229

Similar articles for PubMed (Select 22911670)


Effect of inhibition of the lysophosphatidic acid receptor 1 on metastasis and metastatic dormancy in breast cancer.

Marshall JC, Collins JW, Nakayama J, Horak CE, Liewehr DJ, Steinberg SM, Albaugh M, Vidal-Vanaclocha F, Palmieri D, Barbier M, Murone M, Steeg PS.

J Natl Cancer Inst. 2012 Sep 5;104(17):1306-19. doi: 10.1093/jnci/djs319. Epub 2012 Aug 21.


Targeting lysophosphatidic acid receptor type 1 with Debio 0719 inhibits spontaneous metastasis dissemination of breast cancer cells independently of cell proliferation and angiogenesis.

David M, Ribeiro J, Descotes F, Serre CM, Barbier M, Murone M, Cl├ęzardin P, Peyruchaud O.

Int J Oncol. 2012 Apr;40(4):1133-41. doi: 10.3892/ijo.2011.1309. Epub 2011 Dec 20.


Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer.

Palmieri D, Halverson DO, Ouatas T, Horak CE, Salerno M, Johnson J, Figg WD, Hollingshead M, Hursting S, Berrigan D, Steinberg SM, Merino MJ, Steeg PS.

J Natl Cancer Inst. 2005 May 4;97(9):632-42.


Nm23-h1 binds to gelsolin and inactivates its actin-severing capacity to promote tumor cell motility and metastasis.

Marino N, Marshall JC, Collins JW, Zhou M, Qian Y, Veenstra T, Steeg PS.

Cancer Res. 2013 Oct 1;73(19):5949-62. doi: 10.1158/0008-5472.CAN-13-0368. Epub 2013 Aug 12.


Nm23-H1 suppresses metastasis by inhibiting expression of the lysophosphatidic acid receptor EDG2.

Horak CE, Mendoza A, Vega-Valle E, Albaugh M, Graff-Cherry C, McDermott WG, Hua E, Merino MJ, Steinberg SM, Khanna C, Steeg PS.

Cancer Res. 2007 Dec 15;67(24):11751-9.


Tranilast inhibits the growth and metastasis of mammary carcinoma.

Chakrabarti R, Subramaniam V, Abdalla S, Jothy S, Prud'homme GJ.

Anticancer Drugs. 2009 Jun;20(5):334-45. doi: 10.1097/CAD.0b013e328327994e.


Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells.

Park SJ, Lee KP, Kang S, Chung HY, Bae YS, Okajima F, Im DS.

Cell Signal. 2013 Nov;25(11):2147-54. doi: 10.1016/j.cellsig.2013.07.001. Epub 2013 Jul 6.


Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2.

Horak CE, Lee JH, Elkahloun AG, Boissan M, Dumont S, Maga TK, Arnaud-Dabernat S, Palmieri D, Stetler-Stevenson WG, Lacombe ML, Meltzer PS, Steeg PS.

Cancer Res. 2007 Aug 1;67(15):7238-46.


nm23--relationship to the metastatic potential of breast carcinoma cell lines, primary human xenografts, and lymph node negative breast carcinoma patients.

Russell RL, Geisinger KR, Mehta RR, White WL, Shelton B, Kute TE.

Cancer. 1997 Mar 15;79(6):1158-65.


Lidamycin up-regulates the expression of thymidine phosphorylase and enhances the effects of capecitabine on the growth and pulmonary metastases of murine breast carcinoma.

Zhang SH, Zhang H, He HW, Li L, Li XQ, Zhang YP, Shao RG.

Cancer Chemother Pharmacol. 2013 Oct;72(4):777-88. doi: 10.1007/s00280-013-2253-3. Epub 2013 Aug 23.


Identification of heparin-binding EGF-like growth factor (HB-EGF) as a biomarker for lysophosphatidic acid receptor type 1 (LPA1) activation in human breast and prostate cancers.

David M, Sahay D, Mege F, Descotes F, Leblanc R, Ribeiro J, Cl├ęzardin P, Peyruchaud O.

PLoS One. 2014 May 14;9(5):e97771. doi: 10.1371/journal.pone.0097771. eCollection 2014.


Hypochlorite-induced oxidative stress elevates the capability of HDL in promoting breast cancer metastasis.

Pan B, Ren H, Lv X, Zhao Y, Yu B, He Y, Ma Y, Niu C, Kong J, Yu F, Sun WB, Zhang Y, Willard B, Zheng L.

J Transl Med. 2012 Mar 30;10:65. doi: 10.1186/1479-5876-10-65.


Increased lung metastasis in transgenic NM23-Null/SV40 mice with hepatocellular carcinoma.

Boissan M, Wendum D, Arnaud-Dabernat S, Munier A, Debray M, Lascu I, Daniel JY, Lacombe ML.

J Natl Cancer Inst. 2005 Jun 1;97(11):836-45.


[Molecular mechanism of reversing metastatic phenotype in human high-metastatic large cell lung cancer cell line L9981 by nm23-H1].

Che GW, Zhou QH, Zhu W, Wang YP, Qin Y, Liu LX, Chen XH, Sun YL, Sun ZF.

Ai Zheng. 2005 Mar;24(3):278-84. Chinese.


Licochalcone E present in licorice suppresses lung metastasis in the 4T1 mammary orthotopic cancer model.

Kwon SJ, Park SY, Kwon GT, Lee KW, Kang YH, Choi MS, Yun JW, Jeon JH, Jun JG, Park JH.

Cancer Prev Res (Phila). 2013 Jun;6(6):603-13. doi: 10.1158/1940-6207.CAPR-13-0012. Epub 2013 Apr 26.


Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis.

Dey JH, Bianchi F, Voshol J, Bonenfant D, Oakeley EJ, Hynes NE.

Cancer Res. 2010 May 15;70(10):4151-62. doi: 10.1158/0008-5472.CAN-09-4479. Epub 2010 May 11.


Dietary fat increases solid tumor growth and metastasis of 4T1 murine mammary carcinoma cells and mortality in obesity-resistant BALB/c mice.

Kim EJ, Choi MR, Park H, Kim M, Hong JE, Lee JY, Chun HS, Lee KW, Yoon Park JH.

Breast Cancer Res. 2011 Aug 11;13(4):R78. doi: 10.1186/bcr2927.


Dipyridamole prevents triple-negative breast-cancer progression.

Spano D, Marshall JC, Marino N, De Martino D, Romano A, Scoppettuolo MN, Bello AM, Di Dato V, Navas L, De Vita G, Medaglia C, Steeg PS, Zollo M.

Clin Exp Metastasis. 2013 Jan;30(1):47-68. doi: 10.1007/s10585-012-9506-0. Epub 2012 Jul 4.


Influence of polyamines on in vitro and in vivo features of aggressive and metastatic behavior by human breast cancer cells.

Manni A, Washington S, Griffith JW, Verderame MF, Mauger D, Demers LM, Samant RS, Welch DR.

Clin Exp Metastasis. 2002;19(2):95-105.


An orally active small molecule TGF-beta receptor I antagonist inhibits the growth of metastatic murine breast cancer.

Rausch MP, Hahn T, Ramanathapuram L, Bradley-Dunlop D, Mahadevan D, Mercado-Pimentel ME, Runyan RB, Besselsen DG, Zhang X, Cheung HK, Lee WC, Ling LE, Akporiaye ET.

Anticancer Res. 2009 Jun;29(6):2099-109.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk